Friedrich Graf - Jun 14, 2022 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Chief Medical Officer
Signature
/s/ Friedrich Graf Finckenstein
Stock symbol
IOVA
Transactions as of
Jun 14, 2022
Transactions value $
-$52,634
Form type
4
Date filed
6/16/2022, 05:04 PM
Previous filing
Jan 19, 2022
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOVA Common Stock Options Exercise $0 +19.7K $0.00 19.7K Jun 14, 2022 Direct F1
transaction IOVA Common Stock Tax liability -$52.6K -6.81K -34.58% $7.73 12.9K Jun 14, 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOVA Restricted Stock Units Award $0 +19.7K $0.00 19.7K Jun 14, 2022 Common stock 19.7K Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is the first vesting of the restricted stock units issued on June 14, 2021.
F2 Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities.
F3 Represents the common stock remaining after deducting the common stock withheld for taxes.
F4 Represents restricted stock units remaining after deducting the vested shares of common stock and the common stock withheld for taxes as set forth in Table I above.
F5 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F6 Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date.